Abstract:There have been over 17 million COVID-19 infections worldwide up to July 31, 2020, but the exact transmission route remains a subject for debate. Virus load in different-sized respiratory droplets is the key to address the above question. Investigation on the droplet deposition characteristics during exhalation inside the respiratory tract will facilitate the understanding of their origin and importance in transmitting the respiratory infection. Based on a realistic respiratory model, this study utilized the computational fluid dynamic (CFD) simulation to investigate the deposition of droplets originating from infection sites like pharynx, larynx and trachea under three flow conditions, namely 30 L/min (representing the normal breathing condition), 60 L/min (speaking) and 180 L/min (coughing). The SST k-omega turbulence model integrated in ANSYS Fluent software was utilized to obtain the flow field inside the respiratory tract by solving the continuity and momentum equations, and the Lagrangian approach was used to calculate droplet motion and deposition with the discrete random walk model to account for the turbulence fluctuation effect. Evaporation of droplets was not considered inside the saturated respiratory tract. Droplet diameter, flow rate of the exhaling air, and complexity of the respiratory tract geometry are the most important factors in determining the deposition pattern of respiratory droplets. It is revealed that the largest droplet that originates from the joint of pharynx and larynx and is able to escape out of the respiratory tract is about 20 mu m (30 L/min) or 10 mu m (60-180 L/min) in diameter; the so-called cut-off sizes for vocal cord and trachea originated droplets are 7 mu m (30 L/min), 5 mu m (60 L/min) or 3 mu m (180 L/min). Larynx and joint of larynx and pharynx are the most important deposition sites due to their complexity in geometry and the existence of the laryngeal jet, whose velocity is up to 102 m/s during coughing and 32 m/s during speaking; the nasal cavity is also effective in trapping relatively small droplets as the airflow has a sudden change in direction before entering the oral cavity. Under the investigated speaking scenario (60 L/min), the escape rate of 1 mu m droplets is around 50%, and the maximum escape rates of 5 and 10 mu m droplets are respectively 13.1% and 1.3% (originating from the joint of pharynx and larynx). Although large droplets up to several hundred micrometers can be produced inside the oral cavity due to the atomization mechanism, they seldom carry pathogen. Thus, for COVID-19 patents in the early stage of infection who show upper respiratory symptoms, the cut-off size of virus-laden droplets released into the environment is about 20 mu m; with the shifting of infection to the lower respiratory tract in the later stage, the cut-off size decreases to 7 mu m. Respiratory droplets evaporate immediately after escaping into the indoor environments and shrink to about one third of their initial size, so airborne route is speculated to be important in the transmission of COVID-19. Further investigations considering realistic flow conditions together with droplet sampling experiments on human volunteers are necessary to confirm these cut-off sizes.

Coronavirus Disease 2019 Patients in Earlier Stages Exhaled Millions of Severe Acute Respiratory Syndrome Coronavirus 2 Per Hour

COVID-19 patients in earlier stages exhaled millions of SARS-CoV-2 per hour.

Exhaled breath is a significant source of SARS-CoV-2 emission

High amounts of SARS-CoV-2 in aerosols exhaled by patients with Omicron variant infection

Numerical Investigation on the Origin of Virus-Laden Droplets in the Respiratory Tract

Detection of SARS-CoV-2 in Exhaled Breath from COVID-19 Patients Ready for Hospital Discharge

Corrigendum To: Genomic Diversity of Severe Acute Respiratory Syndrome–Coronavirus 2 in Patients with Coronavirus Disease 2019

Multi-route Transmission Potential of SARS-CoV-2 in Healthcare Facilities.

Breath-, air- and surface-borne SARS-CoV-2 in hospitals

Clinical Features in Coronavirus Disease 2019 (COVID-19) Patients with Early Clearance and Prolonged Shedding of Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2) RNA.

Determinants of SARS-CoV-2 Receptor Gene Expression in Upper and Lower Airways

Severe acute respiratory syndrome coronavirus 2 can be detected in exhaled aerosol sampled during a few minutes of breathing or coughing

Characteristics of COVID-19 Patients With SARS-CoV-2 Positivity in Feces

Aerodynamic Characteristics and RNA Concentration of SARS-CoV-2 Aerosol in Wuhan Hospitals during COVID-19 Outbreak

Detecting SARS-CoV-2 in the Breath of COVID-19 Patients

Transmission and epidemiological characteristics of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infected Pneumonia (COVID-19): preliminary evidence obtained in comparison with 2003-SARS

Assessing Asymptomatic, Presymptomatic, and Symptomatic Transmission Risk of Severe Acute Respiratory Syndrome Coronavirus 2

Aerodynamic analysis of SARS-CoV-2 in two Wuhan hospitals

Research progress of severe acute respiratory syndrome coronavirus 2 on aerosol collection and detection

SARS-CoV-2 presented in the air of an intensive care unit (ICU)

RT-PCR diagnosis of COVID-19 from exhaled breath condensate: a clinical study